Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Dec;88(6):2106–2116. doi: 10.1172/JCI115540

Molecular and cellular actions of platelet-activating factor in rat heart cells.

C V Massey 1, T A Kohout 1, S T Gaa 1, W J Lederer 1, T B Rogers 1
PMCID: PMC295814  PMID: 1661298

Abstract

Platelet-activating factor (PAF) is a phospholipid with cardiovascular actions at low concentrations (1-100 nM) but with uncertain direct myocardial actions. We investigated the cellular and molecular effects of PAF on heart cells using isolated adult and neonatal rat myocytes. Addition of PAF, in the superfusion solution, decreased twitch amplitude and contractile velocity in both systems. Concentrations of PAF below 1 nM stimulated reproducible responses with maximal effects seen at 100 nM. These functional actions of PAF could be blocked by the known PAF antagonist, BN 50739, in a dose-dependent manner. Parallel biochemical studies showed that nanomolar PAF rapidly stimulated the phosphoinositide pathway in cultured myocytes, evidenced by the accumulation of [3H]inositol phosphates in prelabeled cultured myocytes. The potency and specificity of PAF, as well as the time course, for the response were nearly identical in the biochemical and functional assays. PAF produced no functional changes in protein kinase C-depleted myocytes, but it did stimulate inositol trisphosphate accumulation in such cells. We conclude that: (a) PAF exerts a direct negative inotropic effect on myocardial tissue; (b) the effects of PAF are mediated by a specific, high affinity cardiac receptor; (c) an underlying biochemical mechanism for the action of PAF includes the activation of the phospholipase C/phosphatidylinositol intracellular signaling pathway, which leads to activation of protein kinase C.

Full text

PDF
2106

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdellatif M. M., Neubauer C. F., Lederer W. J., Rogers T. B. Angiotensin-induced desensitization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor. Circ Res. 1991 Sep;69(3):800–809. doi: 10.1161/01.res.69.3.800. [DOI] [PubMed] [Google Scholar]
  2. Allen I. S., Cohen N. M., Dhallan R. S., Gaa S. T., Lederer W. J., Rogers T. B. Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: insights into the underlying biochemical mechanisms. Circ Res. 1988 Mar;62(3):524–534. doi: 10.1161/01.res.62.3.524. [DOI] [PubMed] [Google Scholar]
  3. Alloatti G., Montrucchio G., Camussi G. Prostacyclin inhibits the platelet-dependent effects of platelet-activating factor in the rabbit isolated heart. J Cardiovasc Pharmacol. 1990 May;15(5):745–751. doi: 10.1097/00005344-199005000-00009. [DOI] [PubMed] [Google Scholar]
  4. Benveniste J., Boullet C., Brink C., Labat C. The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations. Br J Pharmacol. 1983 Sep;80(1):81–83. doi: 10.1111/j.1476-5381.1983.tb11052.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benveniste J., Henson P. M., Cochrane C. G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med. 1972 Dec 1;136(6):1356–1377. doi: 10.1084/jem.136.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Braquet P., Paubert-Braquet M., Koltai M., Bourgain R., Bussolino F., Hosford D. Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol Sci. 1989 Jan;10(1):23–30. doi: 10.1016/0165-6147(89)90103-x. [DOI] [PubMed] [Google Scholar]
  7. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  8. Capogrossi M. C., Kaku T., Filburn C. R., Pelto D. J., Hansford R. G., Spurgeon H. A., Lakatta E. G. Phorbol ester and dioctanoylglycerol stimulate membrane association of protein kinase C and have a negative inotropic effect mediated by changes in cytosolic Ca2+ in adult rat cardiac myocytes. Circ Res. 1990 Apr;66(4):1143–1155. doi: 10.1161/01.res.66.4.1143. [DOI] [PubMed] [Google Scholar]
  9. Cohen N. M., Lederer W. J. Changes in the calcium current of rat heart ventricular myocytes during development. J Physiol. 1988 Dec;406:115–146. doi: 10.1113/jphysiol.1988.sp017372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Döemeci A., Dhallan R. S., Cohen N. M., Lederer W. J., Rogers T. B. Phorbol ester increases calcium current and simulates the effects of angiotensin II on cultured neonatal rat heart myocytes. Circ Res. 1988 Feb;62(2):347–357. doi: 10.1161/01.res.62.2.347. [DOI] [PubMed] [Google Scholar]
  11. Feuerstein G., Hallenbeck J. M. Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol. 1987;27:301–313. doi: 10.1146/annurev.pa.27.040187.001505. [DOI] [PubMed] [Google Scholar]
  12. Gwathmey J. K., Hajjar R. J. Effect of protein kinase C activation on sarcoplasmic reticulum function and apparent myofibrillar Ca2+ sensitivity in intact and skinned muscles from normal and diseased human myocardium. Circ Res. 1990 Sep;67(3):744–752. doi: 10.1161/01.res.67.3.744. [DOI] [PubMed] [Google Scholar]
  13. Hanahan D. J., Kumar R. Platelet activating factor; chemical and biochemical characteristics. Prog Lipid Res. 1987;26(1):1–28. doi: 10.1016/0163-7827(87)90006-3. [DOI] [PubMed] [Google Scholar]
  14. Handley D. A. Preclinical and clinical pharmacology of platelet-activating factor receptor antagonists. Med Res Rev. 1990 Jul-Sep;10(3):351–370. doi: 10.1002/med.2610100304. [DOI] [PubMed] [Google Scholar]
  15. Hwang S. B. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem. 1988 Mar 5;263(7):3225–3233. [PubMed] [Google Scholar]
  16. Kenzora J. L., Pérez J. E., Bergmann S. R., Lange L. G. Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. J Clin Invest. 1984 Oct;74(4):1193–1203. doi: 10.1172/JCI111528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leprán I., Lefer A. M. Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. Basic Res Cardiol. 1985 Mar-Apr;80(2):135–141. doi: 10.1007/BF01910460. [DOI] [PubMed] [Google Scholar]
  18. Levi R., Burke J. A., Guo Z. G., Hattori Y., Hoppens C. M., McManus L. M., Hanahan D. J., Pinckard R. N. Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. Circ Res. 1984 Feb;54(2):117–124. doi: 10.1161/01.res.54.2.117. [DOI] [PubMed] [Google Scholar]
  19. Montrucchio G., Alloatti G., Mariano F., de Paulis R., Comino A., Emanuelli G., Camussi G. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am J Pathol. 1990 Jul;137(1):71–83. [PMC free article] [PubMed] [Google Scholar]
  20. Montrucchio G., Alloatti G., Tetta C., De Luca R., Saunders R. N., Emanuelli G., Camussi G. Release of platelet-activating factor from ischemic-reperfused rabbit heart. Am J Physiol. 1989 Apr;256(4 Pt 2):H1236–H1246. doi: 10.1152/ajpheart.1989.256.4.H1236. [DOI] [PubMed] [Google Scholar]
  21. Montrucchio G., Camussi G., Tetta C., Emanuelli G., Orzan F., Libero L., Brusca A. Intravascular release of platelet-activating factor during atrial pacing. Lancet. 1986 Aug 2;2(8501):293–293. doi: 10.1016/s0140-6736(86)92118-5. [DOI] [PubMed] [Google Scholar]
  22. Movsesian M. A., Thomas A. P., Selak M., Williamson J. R. Inositol trisphosphate does not release Ca2+ from permeabilized cardiac myocytes and sarcoplasmic reticulum. FEBS Lett. 1985 Jun 17;185(2):328–332. doi: 10.1016/0014-5793(85)80932-7. [DOI] [PubMed] [Google Scholar]
  23. Nosek T. M., Williams M. F., Zeigler S. T., Godt R. E. Inositol trisphosphate enhances calcium release in skinned cardiac and skeletal muscle. Am J Physiol. 1986 May;250(5 Pt 1):C807–C811. doi: 10.1152/ajpcell.1986.250.5.C807. [DOI] [PubMed] [Google Scholar]
  24. Prescott S. M., Zimmerman G. A., McIntyre T. M. Platelet-activating factor. J Biol Chem. 1990 Oct 15;265(29):17381–17384. [PubMed] [Google Scholar]
  25. Robertson D. A., Genovese A., Levi R. Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study. J Pharmacol Exp Ther. 1987 Dec;243(3):834–839. [PubMed] [Google Scholar]
  26. Robertson D. A., Wang D. Y., Lee C. O., Levi R. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity. J Pharmacol Exp Ther. 1988 Apr;245(1):124–128. [PubMed] [Google Scholar]
  27. Rogers T. B., Gaa S. T., Massey C., Dösemeci A. Protein kinase C inhibits Ca2+ accumulation in cardiac sarcoplasmic reticulum. J Biol Chem. 1990 Mar 15;265(8):4302–4308. [PubMed] [Google Scholar]
  28. Salari H., Duronio V., Howard S., Demos M., Pelech S. L. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets. Biochem J. 1990 May 1;267(3):689–696. doi: 10.1042/bj2670689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stahl G. L., Terashita Z., Lefer A. M. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. J Pharmacol Exp Ther. 1988 Mar;244(3):898–904. [PubMed] [Google Scholar]
  30. Sybertz E. J., Watkins R. W., Baum T., Pula K., Rivelli M. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. J Pharmacol Exp Ther. 1985 Jan;232(1):156–162. [PubMed] [Google Scholar]
  31. Tahraoui L., Floch A., Mondot S., Cavero I. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. Mol Pharmacol. 1988 Aug;34(2):145–151. [PubMed] [Google Scholar]
  32. Vites A. M., Pappano A. Inositol 1,4,5-trisphosphate releases intracellular Ca2+ in permeabilized chick atria. Am J Physiol. 1990 Jun;258(6 Pt 2):H1745–H1752. doi: 10.1152/ajpheart.1990.258.6.H1745. [DOI] [PubMed] [Google Scholar]
  33. Yuan S. H., Sunahara F. A., Sen A. K. Tumor-promoting phorbol esters inhibit cardiac functions and induce redistribution of protein kinase C in perfused beating rat heart. Circ Res. 1987 Sep;61(3):372–378. doi: 10.1161/01.res.61.3.372. [DOI] [PubMed] [Google Scholar]
  34. Yue T. L., Farhat M., Rabinovici R., Perera P. Y., Vogel S. N., Feuerstein G. Protective effect of BN 50739, a new platelet-activating factor antagonist, in endotoxin-treated rabbits. J Pharmacol Exp Ther. 1990 Sep;254(3):976–981. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES